Is the Options Market Predicting a Spike in CONMED Stock?

Investors need to pay close attention to CNMD stock based on the movements in the options market lately.

Zacks Investment Research • May 14, 2026

CONMED Corporation (CNMD) Q1 2026 Earnings Call Transcript

CONMED Corporation (CNMD) Q1 2026 Earnings Call Transcript

Seeking Alpha • Apr 30, 2026

CONMED's Q1 Earnings and Revenues Beat, Organic Sales Outlook Up

CNMD tops Q1 estimates despite sales dip, lifts 2026 organic growth outlook as strategic shift sharpens focus on higher-growth segments.

Zacks Investment Research • Apr 30, 2026

CONMED Corporation Announces First Quarter 2026 Financial Results

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2026. First Quarter 2026 Highlights Sales of $317.0 million decreased 1.3% year-over-year as reported and 2.9% in constant currency. Net sales growth was impacted by a $15.5 million decrease in sales from the exit of certain GI products. Domestic revenue decreased 5.8% year-over-year. Domestic sales growth was impacted by a $15.2 million decrease in sales from th.

Business Wire • Apr 29, 2026

Conmed (CNMD) Q1 Earnings and Revenues Beat Estimates

Conmed (CNMD) came out with quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of $0.82 per share. This compares to earnings of $0.95 per share a year ago.

Zacks Investment Research • Apr 29, 2026

Compared to Estimates, Conmed (CNMD) Q1 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Conmed (CNMD) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Investment Research • Apr 30, 2026

Here's Why You Should Retain CONMED Stock in Your Portfolio Now

CNMD's high-margin platforms, supply-chain recovery and margin expansion plans support growth, though tariffs and portfolio shifts weigh on near-term results.

Zacks Investment Research • Apr 9, 2026

CONMED Corporation to Announce First Quarter 2026 Financial Results on April 29, 2026

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2026 after the market close on Wednesday, April 29, 2026. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed fro.

Business Wire • Apr 2, 2026

Conmed (CNMD) Up 22.9% Since Last Earnings Report: Can It Continue?

Conmed (CNMD) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Feb 27, 2026

Here's Why You Should Retain CONMED Stock in Your Portfolio for Now

CNMD's growth rests on AirSeal, Buffalo Filter and BioBrace as supply chains normalize, even as tariffs and a GI exit pressure EPS.

Zacks Investment Research • Feb 10, 2026